| 查看: 627 | 回复: 3 | ||
| 本帖产生 1 个 翻译EPI ，点击这里进行查看 | ||
yin198716新虫 (正式写手)
|
[求助]
求助翻译
|
|
| Tumor angiogenesis is essential for tumor growth and metastasis and is triggered by a variety of proangiogenic factors, regulated by many angiogenic pathways. The most important and best characterized is the VEGF pathway . Blockade of VEGF signaling inhibits tumor angiogenesis and growth in various preclinical models and having systemic effects . The effect of anti-VEGF strategy has been validated in randomized phase III clinical trials. Disruption of VEGF signaling by using bevacizumab, a humanized anti-human VEGF antibody or sorafenib and sunitinib, 2 small chemical inhibitors of receptor-tyrosine kinases (RTK) including VEGF receptors have yielded a significant improvement in progression-free survival but rarely in overall survival for patients with several types of cancers including metastatic colorectal cancer , advanced non–small cell lung cancer , metastatic breast cancer , advanced clear-cell renal-cell carcinoma and advanced hepatocellular carcinoma . |
回复此楼» 猜你喜欢
药学105500专硕289分求调剂
已经有3人回复
-
0703总分331求调剂
已经有15人回复
-
一志愿北京2，材料与化工308求调剂
已经有13人回复
-
318求调剂
已经有14人回复
-
285求调剂
已经有10人回复
-
312求调剂
已经有11人回复
-
273求调剂
已经有6人回复
-
生物学308分求调剂（一志愿华东师大）
已经有8人回复
-
生物学求调剂 一志愿沪9，326分
已经有3人回复
-
080500求调剂
已经有6人回复
2楼2013-04-07 17:51:28
Rio2016
木虫 (小有名气)
- 翻译EPI: 72
- 应助: 28 (小学生)
- 贵宾: 0.013
- 金币: 3301.7
- 散金: 25
- 红花: 6
- 帖子: 300
- 在线: 243.3小时
- 虫号: 1910117
- 注册: 2012-07-25
- 专业: 抗肿瘤药物药理
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
yin198716: 金币+15, 翻译EPI+1, ★有帮助 2013-04-08 17:15:02
yin198716: 金币+15, 翻译EPI+1, ★有帮助 2013-04-08 17:15:02
|
Tumor angiogenesis is essential for tumor growth and metastasis and is triggered by a variety of proangiogenic factors, regulated by many angiogenic pathways. 肿瘤血管新生是肿瘤生长和转移所必需的，它由多种促血管形成因子触发并受多种血管新生通路调控。 The most important and best characterized is the VEGF pathway . 最重要和最有特点的就是VEGF通路。 Blockade of VEGF signaling inhibits tumor angiogenesis and growth in various preclinical models and having systemic effects . 在多种临床前模型中，阻断VEGF信号会抑制肿瘤血管新生和肿瘤生长，并且会有系统性的效应。 The effect of anti-VEGF strategy has been validated in randomized phase III clinical trials. 抗VEGF策略的作用在随机III期临床试验中得到巩固。 Disruption of VEGF signaling by using bevacizumab, a humanized anti-human VEGF antibody or sorafenib and sunitinib, 2 small chemical inhibitors of receptor-tyrosine kinases (RTK) including VEGF receptors have yielded a significant improvement in progression-free survival but rarely in overall survival for patients with several types of cancers including metastatic colorectal cancer , advanced non–small cell lung cancer , metastatic breast cancer , advanced clear-cell renal-cell carcinoma and advanced hepatocellular carcinoma . 用贝伐单抗（人源化的抗VEGF抗体）或用索拉非尼和舒尼替尼（受体络氨酸激酶的两种化学抑制剂） 破坏VEGF信号，可以显著改善无进展生存期，但对同时患有多种癌症病人的总体存活率的改善并不大，包括转移性结直肠癌、晚期非小细胞肺癌、转移性乳腺癌、晚期透明性肾细胞癌和晚期肝癌。 收录到淘贴专辑 |
3楼2013-04-08 10:26:41
yin198716
新虫 (正式写手)
- 应助: 2 (幼儿园)
- 金币: 1682.3
- 散金: 1
- 帖子: 724
- 在线: 566.6小时
- 虫号: 1574633
- 注册: 2012-01-12
- 专业: 呼吸系统肿瘤
4楼2013-04-08 10:58:13
